Publicacións nas que colabora con DIEGO SALAGRE SIMÓN (8)

2024

  1. Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats

    Biomedicine and Pharmacotherapy, Vol. 172

  2. Corrigendum to “Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats” [Biomed. Pharmacother. 172 (2024) 116314] (Biomedicine & Pharmacotherapy (2024) 172, (S0753332224001951), (10.1016/j.biopha.2024.116314))

    Biomedicine and Pharmacotherapy

  3. Synthesis and Anti-Diabetic Activity of an 8-Purine Derivative as a Novel DPP-4 Inhibitor in Obese Diabetic Zücker Rats

    Drug Design, Development and Therapy, Vol. 18, pp. 1133-1141

2023

  1. Melatonin Improves Skeletal Muscle Structure and Oxidative Phenotype by Regulating Mitochondrial Dynamics and Autophagy in Zücker Diabetic Fatty Rat

    Antioxidants, Vol. 12, Núm. 8

2022

  1. Melatonin induces fat browning by transdifferentiation of white adipocytes and de novo differentiation of mesenchymal stem cells

    Food and Function, Vol. 13, Núm. 6, pp. 3760-3775

2021

  1. Melatonin enhances the mitochondrial functionality of brown adipose tissue in obese—diabetic rats

    Antioxidants, Vol. 10, Núm. 9

  2. Melatonin improves endoplasmic reticulum stress-mediated ire1α pathway in zücker diabetic fatty rat

    Pharmaceuticals, Vol. 14, Núm. 3

  3. Melatonin improves levels of zn and cu in the muscle of diabetic obese rats

    Pharmaceutics, Vol. 13, Núm. 10